Winter is a heavenly time to stay home in the evening and have a nice homemade meal. Sounds like a healthy and straightforward thought, but there is more.
Other than relaxing and resting in the comfort of your private habitat, it seems that we may have found a way to lower type-2 diabetes risk. A recent study by Harvard researchers posits that for each lunch prepared at home in a week, the risk of type-2 diabetes dropped by two percent. For each dinner prepared at home, the risk decreased by four percent.
How might eating at home be more beneficial to your health? Eating more homemade meals may help lessen weight gain, which, in turn, can help reduce the risk of developing type-2 diabetes, the researchers explained. Sounds like a good start to fight the silent epidemic that is the reality of 387 million people over the world.
This week’s compilation of pharma articles brings along some interesting news on multichannel strategy, HCP engagement, life sciences M&A and more. In addition, as part of National Diabetes Month, we thought it would be interesting to mention the newly launched ACC and PatientsLikeMe partnership and present a particularly sweet and straightforward article from The Mighty on 18 Truths People With Type-1 Diabetes Wish Others Understood.
1. 18 Truths People with Type 1 Diabetes Wish Others Understood
By Elisabeth Brentano, published on The MIGHTY
“Listening to the patient’s voice”, “patient centricity”, “social listening” – are all nice buzz terms, heavily highlighted throughout this last year in Pharma. A collaboration between “The Mighty” and the “Diabetes Research Institute” took the buzz words and turned them into practice by asking diabetes patients one simple question: “what do you want others to understand about type 1 diabetes?”. The result is a compile of views, providing an insightful glimpse into the experience of being a diabetes patient.
2. What Procter & Gamble Can Teach the Health Care Industry: Assume Nothing About Patients
By Sachin Jain, published on Forbes
Sometimes the solution to finding out what consumers want and need is simply to ask them. That is exactly what Sachin Jain did as the Chief Medical Officer at CareMore Health System. Taking an example from P&G’s CEO, AG Lafley, who instituted the practice of meeting with consumers to better understand their experience with company’s products, Jain began regularly meeting with patients over meals. His insights from this process are presented in this article, all leading to the conclusion that assumptions about patients have no room when it comes to providing healthcare.
A recent surveys show that there’s a significant imbalance between the content and information needs of healthcare professionals (HCP’s) and what is provided by the Pharma industry, manifested in three main areas: content types, channels and format/features. Inability or reluctance to provide the needed content in the needed format through requested channels can lead to lack of engagement and trust. In this article, Michelle Kelly provides a few recommendations for the Pharma industry to address this issue and restore balance.
4. Drug-fuelled Couplings – Why Giant Mergers are Especially Popular among Drugmakers
Published on The Economist
The volume of M&A in the Pharma industry has reached an all-time high this past year. The reasons driving this phenomenon are partly generic, revolving around tax savings and efficiency gains; however, some reasons derive from Pharma specific market shifts. Exorbitant costs, high risks involved in developing new products, expiry of patents on existing drugs, are only a few reasons driving Pharma companies to rely on M&A’s as a survival strategy, and these aren’t going away any time soon.
Gartner predicts that by 2020 the customer will manage 85% of the relationship with an enterprise without interacting with a human. Therefore, implementing a multichannel strategy to interact with customers will become a key component for all enterprises in the upcoming years. According to David Moore, group director at Ashfield Healthcare Communications, this means “Pharma needs to work quickly to connect its touchpoints with its audiences.” This article provides the three pivotal areas that need to be addressed in order to do that: behavior, strategy and implementation. Read on to find out how to incorporate change in each area to create an efficient multichannel strategy in your organization.
https://www.verix.com/wp-content/uploads/2016/02/Nov-12-2015.jpg300670Gili Keshethttps://www.verix.com/wp-content/uploads/2021/03/Growth-Science-45.pngGili Keshet2015-11-12 11:43:322019-11-10 07:45:095 Pharma Articles to Heal Your Bad Habits